Characteristics of mesenchymal stem cells - New stars in regenerative medicine or unrecognized old fellows in autologous regeneration?

Transfusion Medicine and Hemotherapy

Volumn 35, Issue 3, 2008, Pages 154-159

  Schäfer, Richard ^a   Northoff, Hinnak ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Characterization; Differentiation; Marrow stromal cells; Mesenchymal stem cells; Regeneration

Indexed keywords

5' NUCLEOTIDASE; ENDOGLIN; THY 1 ANTIGEN;

ADIPOSE TISSUE; B LYMPHOCYTE; BLOOD VESSEL; BONE MARROW; BRAIN; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL INTERACTION; CELL STRUCTURE; IMMUNOMODULATION; KIDNEY; LIVER; LUNG; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; MUSCLE; OSTEOBLAST; PANCREAS; PARACRINE SIGNALING; PHENOTYPE; PLURIPOTENT STEM CELL; REGENERATIVE ABILITY; REGENERATIVE MEDICINE; REVIEW; SPLEEN; T LYMPHOCYTE; THYMUS; TOTIPOTENT STEM CELL; TUMOR CELL; UMBILICAL CORD BLOOD;

EID: 49649102082     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135634     Document Type: Review

References (67)

1. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3(4):393-403.
2. Friedenstein AJ: Precursor cells of mechanocytes. Int Rev Cytol 1976;47:327-359.
3. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL: Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002;30(7):783-791.
4. Martinez C, Hofmann TJ, Marino R, Dominici M, Horwitz EM: Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 2007;109(10):4245-4248.
5. Giesert C, Marxer A, Sutherland DR, Schuh AC, Kanz L, Buhring HJ: Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34-hematopoietic and mesenchymal stem cell subsets. Ann N Y Acad Sci 2003;996:227-230.
6. Bühring HJ, Kuci S, Conze T, Rathke G, Bartolovic K, Grunebach F, Scherl-Mostageer M, Brummendorf TH, Schweifer N, Lammers R: CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin. Stem Cells 2004;22(3):334-343.
7. Phinney DG, Prockop DJ: Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007;25(11):2896-2902.
8. Javazon EH, Beggs KJ, Flake AW: Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004;32(5):414-425.
9. Phinney DG: Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl 2002;38:7-12.
10. Schäfer R, Dominici M, Muller I, Dazzi F, Bieback K, Godthardt K, Blanc KL, Meisel R, Pochampally R, Richter R, Skutella T, Steinhoff G, Mitterberger M, Wendel H, Wiskirchen J, Handgretinger R, Northoff H: Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tubingen, Germany. Cytotherapy 2007;9(4):397-405.
11. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-317.
12. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ: Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103(5):1662-1668.
13. Verfaillie CM, Pera MF, Lansdorp PM: Stem cells: hype and reality. Hematol Am Soc Hematol Educ Program 2002;369-391.
14. Chamberlain G, Fox J, Ashton B, Middleton J: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25(11):2739-2749.
15. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM: Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A 2004;101(32):11761- 11766.
16. Baksh D, Zandstra PW, Davies JE: A non-contact suspension culture approach to the culture of osteogenic cells derived from a CD49e(low) subpopulation of human bone marrow-derived cells. Biotechnol Bioeng 2007;98(6):1195-1208.
17. Guo KT, Schäfer R, Paul A, Gerber A, Ziemer G, Wendel HP: A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 2006;24(10):2220-2231.
18. Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, Chen W, Ried T, Shi S: Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006;24(4):1095-1103.
19. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, Tahan SR: Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20(1):102-107.
20. Baksh D, Davies JE, Zandstra PW: Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. Blood 2005;106(9):3012-3019.
21. Dorshkind K, Johnson A, Collins L, Keller GM, Phillips RA: Generation of purified stromal cell cultures that support lymphoid and myeloid precursors. J Immunol Methods 1986;89(1):37-47.
22. Johnson A, Dorshkind K: Stromal cells in myeloid and lymphoid long-term bone marrow cultures can support multiple hemopoietic lineages and modulate their production of hemopoietic growth factors. Blood 1986;68(6):1348-1354.
23. Ratajczak MZ, Zuba-Surma EK, Machalinski B, Kucia M: Bone-marrow-derived stem cells - our key to longevity? J Appl Genet 2007;48(4):307-319.
24. da Silva ML, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119(Pt 11):2204-2213.
25. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 2006;24(5):1294-1301.
26. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J: Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 2004;18(1):29-40.
27. Kim S, Honmou O, Kato K, Nonaka T, Houkin K, Hamada H, Kocsis JD: Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res 2006;1123(1):27-33.
28. Faast R, Harrison SJ, Beebe LF, McIlfatrick SM, Ashman RJ, Nottle MB: Use of adult mesenchymal stem cells isolated from bone marrow and blood for somatic cell nuclear transfer in pigs. Cloning Stem Cells 2006;8(3):166-173.
29. Guo KT, Schäfer R, Paul A, Ziemer G, Wendel HP: Aptamer-based strategies for stem cell research. Mini Rev Med Chem 2007;7(7):701-705.
30. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-147.
31. Tondreau T, Lagneaux L, Dejeneffe M, Delforge A, Massy M, Mortier C, Bron D: Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy 2004;6(4):372-379.
32. Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H: Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 2007;244(2):514-523.
33. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montagna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F: Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67(19):9142-9149.
34. Song L, Tuan RS: Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 2004;18(9):980-982.
35. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop DJ: Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 1999;75(3):424-436.
36. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG: Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997;12(9):1335-1347.
37. Muraglia A, Cancedda R, Quarto R: Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113(Pt 7):1161-1166.
38. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ: Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999;107(2):275-281.
39. Kopen GC, Prockop DJ, Phinney DG: Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999;96(19):10711-10716.
40. Pacary E, Legros H, Valable S, Duchatelle P, Lecocq M, Petit E, Nicole O, Bernaudin M: Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J Cell Sci 2006;119(Pt 13):2667-2678.
41. Wakitani S, Saito T, Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18(12):1417-1426.
42. Hattan N, Kawaguchi H, Ando K, Kuwabara E, Fujita J, Murata M, Suematsu M, Mori H, Fukuda K: Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res 2005;65(2):334-344.
43. Dezawa M: Insights into autotransplantation: the unexpected discovery of specific induction systems in bone marrow stromal cells. Cell Mol Life Sci 2006;63(23):2764-2772.
44. Uccelli A, Zappia E, Benvenuto F, Frassoni F, Mancardi G: Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opin Biol Ther 2006;6(1):17-22.
45. Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H, Kocsis JD: Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 2006;199(1):56-66.
46. Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ: Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 2007;354(3):700-706.
47. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ: Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20(6):661-669.
48. Dai Y, Xu M, Wang Y, Pasha Z, Li T, Ashraf M: HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 2007;42(6):1036-1044.
49. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363(9419):1439-1441.
50. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106(5):1755-1761.
51. Comoli P, Ginevri F, Maccario R, Avanzini MA, Marconi M, Groff A, Cometa A, Cioni M, Porretti L, Barberi W, Frassoni F, Locatelli F: Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant 2008;23(4):1196-1202.
52. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D: Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2.3-dioxygenase-mediated tryptophan degradation. Blood 2004;103(12):4619-4621.
53. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA: Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000;164(7):3596-3599.
54. Gieseke F, Schutt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, Muller I: Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood 2007;110(6):2197-2200.
55. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105(4):1815-1822.
56. Nasef A, Mathieu N, Chapel A, Frick J, Francois S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L: Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007;84(2):231-237.
57. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis MA, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE, Blazar BR: Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007;25(2):371-379.
58. Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L: Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006;5(3):755-766.
59. Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, Barry FP, O'Brien T, Kerin MJ: Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007;13(17):5020-5027.
60. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96(21):1593-1603.
61. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449(7162):557-563.
62. Galie M, Konstantinidou G, Peroni D, Scambi I, Marchini C, Lisi V, Krampera M, Magnani P, Merigo F, Montani M, Boschi F, Marzola P, Orru R, Farace P, Sbarbati A, Amici A: Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene 2008;27(18):2542-2551.
63. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F: Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007;21(2):304-310.
64. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276(5309):71-74.
65. Krupp S: [Transformation of monocytes into fibroblasts in wound healing (author's transl)]. Res Exp Med (Berl) 1976;167(2):85-126.
66. Pufe T, Petersen W, Fandrich F, Varoga D, Wruck CJ, Mentlein R, Helfenstein A, Hoseas D, Dressel S, Tillmann B, Ruhnke M: Programmable cells of monocytic origin (PCMO): A source of peripheral blood stem cells that generate collagen type II-producing chondrocytes. J Orthop Res 2008;26:(3)304-313.
67. Jones S, Horwood N, Cope A, Dazzi F: The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 2007;179(5):2824-2831.